Study #PA19-0309
A pilot investigation to determine the utility of liquid biopsies and tumor molecular profiling in predicting recurrence in high-risk endometrial cancers
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study is to find out how well liquid biopsies work as a non-invasive alternative to other methods of finding cancer cells (such as a tissue biopsy) in patients with high-risk endometrial cancer. A liquid biopsy is a blood test that may be able to find cancer cells. Collecting and storing samples of blood and tissue from patients with endometrial cancer to study in the laboratory may help doctors learn how the cells in the blood may change during treatment for uterine cancer.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Endometrial Clear Cell Adenocarcinoma;Endometrial Dedifferentiated Carcinoma;Endometrial Mucinous Adenocarcinoma;Endometrial Serous Adenocarcinoma;Malignant Uterine Neoplasm;Uterine Corpus Carcinosarcoma
Study phase:
Physician name:
Pamela Soliman
Department:
Gynecologic Oncology & Reproductive Medicine
For general questions about clinical trials:
1-855-900-1058
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.